Product Information
GONAL-F RFF REDI-JECT 300 UNITS PEN is a brand product labeled by EMD Serono, Inc., priced at $1866.5467 per ML under NDC 44087111501. Its NADAC has been published 68 times since Apr 17, 2024.
Strength
300 [iU]/.5mL
Manufacturer
EMD Serono, Inc.NDC
44087111501
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
2/19/2025
Active Ingredients
FOLLITROPINApproval Type
Biologic (BLA)
FDA Application
BLA021684On Market Since
10/16/2013
Pharmacological Classes
Price Statistics
The NADAC for GONAL-F RFF REDI-JECT 300 UNITS PEN has been published 68 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1866.5467 per ML |
|---|---|
| All-time high | $1872.9267 (Sep 11, 2024) |
| All-time low | $1858.3160 (Apr 17, 2024) |
| 52-week high | $1866.5467 |
| 52-week low | $1866.5467 |
| Median price | $1866.5467 |
| Average price | $1865.7034 |
| Largest weekly change | +0.8% (Aug 21, 2024) |
| Weeks tracked | 68 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the FOLLITROPIN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GONAL-F RFF REDI-JECT 300 UNITS PEN?
The current National Average Drug Acquisition Cost (NADAC) for GONAL-F RFF REDI-JECT 300 UNITS PEN, manufactured by EMD Serono, Inc., is $1866.5467 per ML (NDC 44087111501), effective Jul 30, 2025.
How has the price of GONAL-F RFF REDI-JECT 300 UNITS PEN changed over time?
Over the history we have for it, the NADAC for GONAL-F RFF REDI-JECT 300 UNITS PEN has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GONAL-F RFF REDI-JECT 300 UNITS PEN?
Since Apr 17, 2024, the NADAC for GONAL-F RFF REDI-JECT 300 UNITS PEN has ranged from a low of $1858.3160 (Apr 17, 2024) to a high of $1872.9267 (Sep 11, 2024), with a median of $1866.5467 per ML.
Are there cheaper alternatives to GONAL-F RFF REDI-JECT 300 UNITS PEN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GONAL-F RFF REDI-JECT 300 UNITS PEN, so no direct lower-cost alternative is listed.
Who manufactures GONAL-F RFF REDI-JECT 300 UNITS PEN?
GONAL-F RFF REDI-JECT 300 UNITS PEN (NDC 44087111501) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification